A functional and histopathological comparison of proximal and distal saphenous vein contractility and morphology

Texas Heart Institute Journal

Volumn 32, Issue 3, 2005, Pages 287-293

  Golbasi, Ilhan ^a   Tasatargil, Arda ^a   Aksoy, Nazif Hikmet ^a   Sadan, Gulay ^a   Karasu, Edibe ^a   Turkay, Cengiz ^a   Bayezid, Omer ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Comparative study; Coronary artery bypass; Extracellular matrix ultrastructure; Graft occlusion, vascular prevention control; Muscle, smooth, vascular; Saphenous vein anatomy histology transplantation; Spasm; Vasoconstriction; Vasodilation

Indexed keywords

ACETYLCHOLINE; ANGIOTENSIN; DILTIAZEM; NITROPRUSSIDE SODIUM; NORADRENALIN; PHENYLEPHRINE; POTASSIUM CHLORIDE;

ADULT; ADVENTITIA; AGED; ARTICLE; BLOOD VESSEL REACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; EXTRACELLULAR MATRIX; GRAFT OCCLUSION; GRAFT PATENCY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTIMA; SAPHENOUS VEIN GRAFT; SMOOTH MUSCLE FIBER; VASOCONSTRICTION; VASODILATATION;

AGED; CORONARY ARTERY BYPASS; CORONARY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; POTASSIUM CHLORIDE; SAPHENOUS VEIN; ULTRASONOGRAPHY, DOPPLER; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 24944588897     PISSN: 07302347     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Izzat MB, West RR, Bryan AJ, Angelini GD. Coronary artery bypass surgery: current practice in the United Kingdom. Br Heart J 1994;71:382-5.
2. Chanda J, Canver CC. Reversal of preexisting vasospasm in coronary artery conduits. Ann Thorac Surg 2001;72:476-80.
3. Reardon MJ, Conklin LD, Reardon PR, Baldwin JC. Coronary artery bypass conduits: review of current status. J Cardiovasc Surg (Torino) 1997;38:201-9.
4. Stooker W, Gok M, Sipkema P, Niessen HW, Baidoshvili A, Westerhof N, et al. Pressure-diameter relationship in the human greater saphenous vein. Ann Thorac Surg 2003;76: 1533-8.
5. Dilley RJ, McGeachie JK, Prendergast FJ. A review of the histologic changes in vein-to-artery grafts, with particular reference to intimal hyperplasia. Arch Surg 1988;123:691-6.
6. Canham PB, Finlay HM, Boughner DR. Contrasting structure of the saphenous vein and internal mammary artery used as coronary bypass vessels. Cardiovasc Res 1997;34: 557-67.
7. Campeau L, Enjalbert M, Lesperance J, Bourassa MG, Kwiterovich P Jr, Wacholder S, Sniderman A. The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation. A study 10 years after aortocoronary bypass surgery. N Engl J Med 1984;311:1329-32.
8. Bourassa MG, Fisher LD, Campeau L, Gillespie MJ, McConney M, Lesperance J. Long-term fate of bypass grafts: the Coronary Artery Surgery Study (CASS) and Montreal Heart Institute experiences. Circulation 1985;72:(6 Pt 2): V71-8.
9. Milroy CM, Scott DJ, Beard JD, Horrocks M, Bradfield JW. Histological appearances of the long saphenous vein. J Pathol 1989;159:311-6.
10. Vermeulen EG, Niessen HW, Bogels M, Stehouwer CD, Rauwerda JA, van Hinsbergh VW. Decreased smooth muscle cell/extracellular matrix ratio of media of femoral artery in patients with atherosclerosis and hyperhomocysteinemia. Arterioscler Thromb Vasc Biol 2001;21:573-7.
11. Chester AH, Marchbank AJ, Borland JA, Yacoub MH, Taggart DP. Comparison of the morphologic and vascular reactivity of the proximal and distal radial artery. Ann Thorac Surg 1998;66:1972-7.
12. He GW, Rosenfeldt FL, Angus JA. Pharmacological relaxation of the saphenous vein during harvesting for coronary artery bypass grafting. Ann Thorac Surg 1993;55:1210-7.
13. Robertson RM, Bernard Y, Robertson D. Arterial and coronary sinus catecholamines in the course of spontaneous coronary artery spasm. Am Heart J 1983;105:901-6.
14. Romero JC, Reckelhoff JF. State-of-the-Art lecture. Role of angiotensin and oxidative stress in essential hypertension. Hypertension 1999;34(4 Pt 2):943-9.
15. He GW, Rosenfeldt FL, Buxton BF, Angus JA. Reactivity of human isolated internal mammary artery to constrictor and dilator agents. Implications for treatment of internal mammary artery spasm. Circulation 1989;80(3 Pt 1):I141-50.
16. el-Sanadiki MN, Cross KS, Murray JJ, Schuman RW, Mikat E, McCann RL, Hagen PO. Reduction of intimal hyperplasia and enhanced reactivity of experimental vein bypass grafts with verapamil treatment. Ann Surg 1990; 212:87-96.
17. Kohler TR. Intimal hyperplasia. In: White RA, Hollier LH, editors. Vascular surgery: basic science and clinical correlations. Philadelphia: Lippincott; 1994. p. 217-25.
18. Ku DD, Caulfield JB, Kirklin JK. Endothelium-dependent responses in long-term human coronary artery bypass grafts. Circulation 1991;83:402-11.
19. Radomski MW, Palmer RM, Moncada S. The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Br J Pharmacol 1987; 92:639-46.
20. Dobrin PB, Littooy FN, Golan J, Blakeman B, Fareed J. Mechanical and histologic changes in canine vein grafts. J Surg Res 1988;44:259-65.
21. Leung DY, Glagov S, Mathews MB. Cyclic stretching stimulates synthesis of matrix components by arterial smooth muscle cells in vitro. Science 1976;191:475-7.
22. Davies AH, Magee TR, Baird RN, Sheffield E, Horrocks M. Vein compliance: a preoperative indicator of vein morphology and of veins at risk of vascular graft stenosis. Br J Surg 1992;79:1019-21.
23. Tyagi SC. Homocyst(e)ine and heart disease: pathophysiology of extracellular matrix. Clin Exp Hypertens 1999;21: 181-98.
24. Tyagi SC, Smiley LM, Mujumdar VS, Clonts B, Parker JL. Reduction-oxidation (Redox) and vascular tissue level of homocyst(e)ine in human coronary atherosclerotic lesions and role in extracellular matrix remodeling and vascular tone. Mol Cell Biochem 1998;181:107-16.
25. Buxton B, Lambert RP, Pitt TT. The significance of vein wall thickness and diameter in relation to the patency of femoropopliteal saphenous vein bypass grafts. Surgery 1980; 87:425-31.